Regulating pharmaceutical companies that manufacture essential health products during a public health emergency is a key flashpoint between developed and developing countries ahead of the final round of talks on the pandemic agreement. This is evident in some of the 17 submissions made to the Intergovernmental Negotiating Working Group (IGWG), which is coordinating the final […] Continue reading ->
There is mounting rage amongst World Health Organization’s (WHO) staff about planned workforce reductions, as new financial data suggests that low- and mid-level personnel are bearing the brunt of cuts—while high-ranking executives, whose real costs far exceed their published salaries, remain largely protected. In an email to WHO staff last week, WHO Director General Dr […] Continue reading ->
China has suggested that the access pharmaceutical manufacturers get to information about dangerous pathogens should be “contingent” on their home country being a party to the Pandemic Agreement recently adopted by the World Health Assembly (WHA). This will encourage World Health Organization (WHO) member states to ratify the agreement in their respective countries, but it […] Continue reading ->